Advicenne S.A. (EPA:ALDVI)
1.740
-0.010 (-0.57%)
At close: Dec 5, 2025
Advicenne Revenue
Advicenne had revenue of 3.27M EUR in the half year ending June 30, 2025, with 91.89% growth. This brings the company's revenue in the last twelve months to 5.90M, down -5.38% year-over-year. In the year 2024, Advicenne had annual revenue of 5.27M, down -0.51%.
Revenue (ttm)
5.90M
Revenue Growth
-5.38%
P/S Ratio
4.18
Revenue / Employee
453.54K
Employees
13
Market Cap
24.65M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.27M | -27.00K | -0.51% |
| Dec 31, 2023 | 5.30M | 1.58M | 42.53% |
| Dec 31, 2022 | 3.72M | -9.00K | -0.24% |
| Dec 31, 2021 | 3.72M | 233.00K | 6.67% |
| Dec 31, 2020 | 3.49M | 907.00K | 35.10% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 27.24B |
| Sanofi | 45.93B |
| Sartorius Stedim Biotech | 2.95B |
| bioMérieux | 4.12B |
| Eurofins Scientific SE | 7.14B |
| Ipsen | 3.76B |
| ABIVAX Société Anonyme | 6.02M |
| Virbac | 1.43B |